tocopheryl nicotinate has been researched along with Hyperlipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakayama, S; Negishi, K; Sakamoto, K | 1 |
| Abe, A; Maeda, S; Muto, Y; Noma, A; Okuno, M | 1 |
1 trial(s) available for tocopheryl nicotinate and Hyperlipidemias
| Article | Year |
|---|---|
Reduction of serum lipoprotein(a) levels in hyperlipidaemic patients with alpha-tocopheryl nicotinate.
Topics: Adult; Aged; Apolipoprotein C-II; Apolipoproteins C; Cholesterol; Cholesterol, HDL; Female; Humans; Hyperlipidemias; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Nicotinic Acids; Probucol; Vitamin E | 1990 |
1 other study(ies) available for tocopheryl nicotinate and Hyperlipidemias
| Article | Year |
|---|---|
[Effects of soysterol, pantethine and dl-alpha-tocopheryl nicotinate on hyperlipemia in rats (author's transl)].
Topics: Animals; Body Weight; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Nicotinic Acids; Organ Size; Pantetheine; Phytosterols; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Vitamin E | 1981 |